tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VIRX

Three new option listings and ten option delistings on July 21st
The FlyThree new option listings and ten option delistings on July 21st
9d ago
YI
HES
Is VIRX a Buy, Before Earnings?
PremiumPre-Earnings
Is VIRX a Buy, Before Earnings?
5M ago
VIRX
Viracta Therapeutics terminates employees, to wind down operations
PremiumThe Fly
Viracta Therapeutics terminates employees, to wind down operations
6M ago
VIRX
Viracta Therapeutics Announces Wind-Down and Leadership Changes
PremiumCompany Announcements
Viracta Therapeutics Announces Wind-Down and Leadership Changes
6M ago
8K
VIRX
Netflix draws big viewership for NFL Christmas games: Morning Buzz
PremiumThe Fly
Netflix draws big viewership for NFL Christmas games: Morning Buzz
7M ago
BA
EH
ServiceTitan initiated, Viracta downgraded: Wall Street’s top analyst calls
PremiumThe FlyServiceTitan initiated, Viracta downgraded: Wall Street’s top analyst calls
7M ago
EL
TME
Viracta Therapeutics downgraded to Neutral from Buy at Rodman & Renshaw
Premium
The Fly
Viracta Therapeutics downgraded to Neutral from Buy at Rodman & Renshaw
7M ago
VIRX
Viracta Therapeutics Explores Strategic Options After NAVAL-1 Closure
Premium
Company Announcements
Viracta Therapeutics Explores Strategic Options After NAVAL-1 Closure
7M ago
8K
VIRX
Viracta Therapeutics announces exploration of strategic alternatives
PremiumThe Fly
Viracta Therapeutics announces exploration of strategic alternatives
7M ago
VIRX
Viracta Therapeutics Highlights Strategic Focus and Financials
PremiumCompany Announcements
Viracta Therapeutics Highlights Strategic Focus and Financials
9M ago
VIRX
Viracta Therapeutics reports Q3 EPS (27c) vs (33c) last year
PremiumThe Fly
Viracta Therapeutics reports Q3 EPS (27c) vs (33c) last year
9M ago
VIRX
Viracta Therapeutics expects cash to fund operations into Q1 of 2025
PremiumThe Fly
Viracta Therapeutics expects cash to fund operations into Q1 of 2025
9M ago
VIRX
Viracta Therapeutics reports 42% reduction in force, strategic reprioritization
PremiumThe FlyViracta Therapeutics reports 42% reduction in force, strategic reprioritization
9M ago
VIRX
Viracta Therapeutics Restructures to Focus on Nana-val Program
Premium
Company Announcements
Viracta Therapeutics Restructures to Focus on Nana-val Program
9M ago
8K
VIRX
VIRX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
VIRX Upcoming Earnings Report: What to Expect?
9M ago
VIRX
Viracta Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Viracta Therapeutics downgraded to Market Perform from Outperform at Leerink
12M ago
VIRX
Viracta Therapeutics price target lowered to $4 from $6 at RBC Capital
PremiumThe Fly
Viracta Therapeutics price target lowered to $4 from $6 at RBC Capital
12M ago
VIRX
Viracta Therapeutics Announces Key Business Developments
PremiumCompany Announcements
Viracta Therapeutics Announces Key Business Developments
12M ago
8K
VIRX
Viracta Therapeutics announces data from Phase 2 NAVAL-1 trial
PremiumThe Fly
Viracta Therapeutics announces data from Phase 2 NAVAL-1 trial
12M ago
VIRX
Viracta Therapeutics reports Q2 EPS (25c) vs (32c) lastyear
PremiumThe FlyViracta Therapeutics reports Q2 EPS (25c) vs (32c) lastyear
12M ago
VIRX
VIRX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
VIRX Upcoming Earnings Report: What to Expect?
12M ago
VIRX
Xoma receives $8.1M milestone related to Day One’s sale of PRV
Premium
The Fly
Xoma receives $8.1M milestone related to Day One’s sale of PRV
1y ago
DAWN
VIRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >